Return
Childhood ocular safety after postnatal exposure to topical dexamethasone during retinopathy of prematurity screening
M
A
A
P
DOI:10.1111/aos.70189.png)
Abstract
En 中文
Dexamethasone eye drops are being introduced off-label to prevent progression of severe retinopathy of prematurity (ROP). We evaluated ophthalmologic outcomes in early childhood after postnatal topical dexamethasone exposure in pre-term infants at a standardized follow-up examination.
Keywords:
dexamethasone
follow-up
preterm infant
retinopathy of prematurity
Journal
IF:
2.8
Papers:
1.1W
Citations:
1.1W
